Home / Technical Advisory Boards

Technical Advisory Boards

The Technical Advisory Boards (ABs) of the Parenteral Drug Association (PDA) provide scientific and technical expertise to the PDA Board of Directors as well as day to day content management of scientific and technical initiatives intended for PDA publication. The ABs guide and support the development of Technical Reports, Standards, Points for Consideration documents, PDA Research, and PDA Journal and PDA Letter articles. The ABs collaborate on matters of overlapping expertise and relevance, including best practice and new concept development, implementation, and communication. As appropriate, each develops and makes recommendations to the PDA Board of Directors on proposed PDA positions, which may include comments to regulators. The four ABs support the creation and ongoing activities of Interest Groups in which PDA members review, discuss, and advance industry understanding of technical and quality topics. Each also contributes to PDA’s educational mission by assisting the Training and Research Institute (TRI) in curriculum development.
Quick Links
ATMP AB (Advanced Therapy Medicinal Products Advisory Board)

The ATMP AB is composed of a diverse group of experts drawn from industry, regulatory agencies, and academia who provide guidance and set strategic manufacturing and quality direction on technical topics associated with cell, gene, tissue, and other novel therapeutic modalities.  These may include:

  • Raw and ancillary materials
  • Drug product and drug product manufacturing science
  • Quality systems
  • Product and process comparability
  • Analytical methods
  • Supply chain
ATMP AB Leadership and AB Members
BioAB (Biopharmaceutical Advisory Board)

The BioAB is composed of a diverse group of experts drawn from industry, regulatory agencies, and academia who provide guidance and set strategic direction on technical topics associated with biopharmaceutical and biotechnology-related manufacturing and quality.  These may include:

  • Raw and ancillary materials
  • Upstream and downstream processing science for biopharmaceutical manufacturing
  • Product class-specific manufacturing and quality testing aspects for vaccines, protein therapeutics, and other biologics
  • Emerging technology, including analytical methodology and data application
BioAB Leadership and AB Members
RAQAB (Regulatory Affairs and Quality Advisory Board)

The RAQAB is composed of a diverse group of experts who provide guidance and set strategic direction on regulatory and quality topics spanning the lifecycle of healthcare products.  These may include:

  • Advancing harmonization, convergence and alignment in the regulatory space through regulatory engagement and advocacy
  • Driving and advancing guidance for industry
  • Scanning and analyzing the regulatory horizon
  • Addressing such quality topics as quality risk management, data integrity, and quality metrics and quality culture
RAQAB Leadership and AB Members
SAB (Science Advisory Board)

The SAB is the longest standing Advisory Board and is composed of a diverse group of experts drawn from industry, regulatory agencies, and academia who provide guidance and set strategic direction for PDA on technical topics associated with pharmaceutical manufacturing and quality. These may include:

  • Aseptic processing, sterility assurance, and microbial testing
  • Manufacturing science
  • Packaging science including visual inspection
  • Product quality analysis and testing
  • Analytical method development
  • Application of data science
SAB Leadership and AB Members